These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 3314257

  • 1. Studies of experimental candidiasis in T-cell-deficient mice.
    Sinha BK, Prasad S, Monga DP.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jun; 265(1-2):203-9. PubMed ID: 3314257
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.
    Fidel PL, Lynch ME, Sobel JD.
    Infect Immun; 1993 May; 61(5):1990-5. PubMed ID: 8097493
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CD4(+)-T-Cell-mediated resistance to systemic murine candidiasis induced by a membrane fraction of Candida albicans.
    Mizutani S, Endo M, Ino-Ue T, Kurasawa M, Uno Y, Saito H, Onogi K, Kato I, Takesako K.
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2653-8. PubMed ID: 10991839
    [Abstract] [Full Text] [Related]

  • 10. Immune responses to yeast and mycelial forms of Candida albicans in intraperitoneally infected mice.
    Ponton J, Regulez P, Cisterna R.
    Mycopathologia; 1986 Apr; 94(1):11-7. PubMed ID: 3523252
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Acquired immunity to systemic candidiasis in immunodeficient mice.
    Cantorna MT, Balish E.
    J Infect Dis; 1991 Nov; 164(5):936-43. PubMed ID: 1940472
    [Abstract] [Full Text] [Related]

  • 13. Validation of a Candida albicans delayed-type hypersensitivity (DTH) model in female juvenile rats for use in immunotoxicity assessments.
    Collinge M, Thorn M, Peachee V, White K.
    J Immunotoxicol; 2013 Nov; 10(4):341-8. PubMed ID: 23282408
    [Abstract] [Full Text] [Related]

  • 14. Effects of cyclophosphamide on murine candidiasis.
    Moser SA, Domer JE.
    Infect Immun; 1980 Feb; 27(2):376-86. PubMed ID: 6991413
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Germling protoplast antigens of Candida albicans in the serodiagnosis of invasive candidosis.
    Mason AB, Smith JM.
    J Infect Dis; 1986 Jan; 153(1):146-50. PubMed ID: 3510259
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antibody formation in experimental immunizations with Candida albicans ribosomal fractions.
    Segal E, Levy R, Eylan E.
    Mycopathologia; 1978 Oct 16; 64(2):121-3. PubMed ID: 366424
    [Abstract] [Full Text] [Related]

  • 20. Increased levels of Candida albicans mannan-specific T-cell-derived antigen binding molecules in patients with invasive candidiasis.
    Kosonen J, Rantala A, Little CH, Lintu P, Harjamäki PR, Georgiou GM, Cone RE, Savolainen J.
    Clin Vaccine Immunol; 2006 Apr 16; 13(4):467-74. PubMed ID: 16603614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.